Form 8-K - Current report:
SEC Accession No. 0001104659-21-151192
Filing Date
2021-12-17
Accepted
2021-12-17 16:40:54
Documents
12
Period of Report
2021-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135755d1_8k.htm   iXBRL 8-K 25911
  Complete submission text file 0001104659-21-151192.txt   196588

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rigl-20211216.xsd EX-101.SCH 3016
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rigl-20211216_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rigl-20211216_pre.xml EX-101.PRE 22353
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2135755d1_8k_htm.xml XML 3504
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29889 | Film No.: 211502171
SIC: 2834 Pharmaceutical Preparations